1Disease Classification
Tetanus
3GTKYCA
GPR, Strict anearobe, lophotrichous flagella, spore forming, produces 2 toxins; Tetanospasim and Tetanolysin
4Epideimology; Reservoir
Enviroment (soil and animals)
5Epidemiology; POE
Open Wound (70% of US cases come from puncture or laceration)
6Epidemiology: MOT
Parenteral Route, Non-Communicable (except during birth)
7Incubation Period
3-21 days
8Pathogenesis
Spores germinate and colonize anearobic wounds. secreted Tetanospasmin toxins enter motor neurons or circulatory system and are transported to the CNS where they target inhibitory neurons resulting in sustained muscle contraction
9S/s
Severe pain; Muscle Spasms: General- increased tone of orbicularis oris, “lockjaw,” trouble swallowing, abdominal rigidity, opisthotonos (curvature of the back); Local- affects muscles at the site of infection; Cephalic- affects cranial nerve muscles; Neonatal- weakness, rigidity, failure to nurse; jerking or staring (seizures); headache, fever and sweating, changes in blood pressure and a fast heart rate, PROGRESSIVE worsening over 2 weeks
10Complications
Spasms obstructing upper airway or diaphragm, broken bones, autonomic dysfunction, blood clot, secondary infection, recurrent tetanus, Mortality in neonatal is 90%
11Prevention
Toxoid Vaccine-DTaP, Tdap, Td (every 10 yrs), disinfect for spores
12Treatment
Ventilation, Benzodiazepines GABA agonists, Passive immunizations with human tetanus immune globin (HTIG), Vaccination, Antiboitics/Metronidazole